###### Strengths and limitations of this study:

-   Large US sample using a robust experimental design, a best--worst scaling, case 2 method, incorporating large numbers of relevant attributes of electronic nicotine delivery systems (ENDS).

-   Consumers found different attributes of ENDS products important to their use.

-   Perceived harms of ENDS use appeared most important to their choice of ENDS products, and modifiability was least important.

-   Variation by consumer group existed, which may allow for targeted interventions to modify ENDS use.

-   Limitations include the convenience sample of US ENDS users, and the use of an experimental design which may invite more socially acceptable responses as opposed to direct purchasing observations.

Introduction {#s1}
============

Although its health effects remain unclear, the use of electronic nicotine delivery systems (ENDS) in the USA continues to grow even in the face of impending regulation.[@R1] While the use of combustible tobacco cigarettes has declined, the US ENDS market now exceeds \$8 billion.[@R2] The rise in the use of ENDS has occurred despite mixed evidence about its harm reduction effects or use as a tobacco cessation aid.[@R4] Given the uncertainty around ENDS, initial regulations were piecemeal and varied from state to state. However, in 2016, the Food and Drug Administration (FDA) issued a regulation deeming ENDS to fall under its authority.[@R5] These regulations will impose a variety of restrictions on ENDS manufacturing, sales and marketing. Notably, however, the FDA has postponed implementation of some of the rules requirements, citing the possibility that ENDS have the 'potential to make a notable public health difference'.[@R6] As the potential benefits and harms of ENDS become clear, regulators and public health groups will need to understand how their proposed regulations will likely affect consumers' use. Consumers use ENDS due to a variety of product attributes that may be amenable to regulation or public health campaigns.[@R7] Regulators and public health groups need to know the incremental role of individual product attributes on the decision to use ENDS products so that they can make evidence-based policies depending on how they want to modify ENDS use.

A widely used method in behavioural economics to understand consumer use is discrete choice experiments (DCE).[@R8] Once the relationship between consumers' use and product attributes is understood, regulators can consider whether and how to address the most important attributes to most of the consumers to either increase or decrease product use. While DCEs have been conducted to examine consumers' attitudes towards combustible tobacco regulations and smoking cessation,[@R10] only one has examined potential ENDS use.[@R15] This recently published study conducted in Canada examined only four ENDS attributes: flavour, nicotine content, health warnings and price[@R15]; finding that health risks and efficacy as a tobacco cessation aid were the two most important attributes to consumers. However, this study only examined four attributes and included non-smokers and non-ENDS users.

Knowledge from our formative qualitative work was used to create a DCE with a larger number of attributes focused on ENDS users. We examined the list of a dozen attributes that are important to consumers, which we developed from a recent structured content analysis.[@R16] Among these 12 attributes, we found 9 attributes that appeared related to the ENDS device itself.[@R16] We chose to look at the device-related attributes because these attributes may be more easily regulated than other psychosocial attributes such as the ability to vape in public or as a social outlet.[@R17] We designed and fielded a DCE study using a best--worst scaling experiment among the national US sample of ENDS users.

Methods {#s2}
=======

Study design {#s2a}
------------

We conducted a one-time survey including a best--worst scaling, case 2 design DCE of the importance of ENDS product attributes. The final version of the survey was fielded using the Research Now survey panel between 26 August and 31 August 2016. Participants were remunerated from Research Now in accordance with their usual rate.

Patient and public involvement {#s2b}
------------------------------

The attributes used in the DCE were developed through focus groups conducted as part of prior research.[@R19] The study involved participants in a pretest phase using an academic mass email system. Twelve individuals pretested the survey between 9 May and 14 May 2016. Incentive for completing the survey included possibly receiving one of four gift cards valued at \$50 each. Feedback from the pretest led to both condensing and simplifying the language of the survey. Clarity of the survey was again improved after another round of testing with 75 survey panellists recruited from Research Now, a research survey company, between 15 August and 16 August 2016. The second episode of testing also led to language alterations surrounding questions on the flavour attribute and its levels to ensure comprehension. Participants were not involved in the recruitment to or conduct of the study. Participants in the final version of the survey did not receive their study results.

Participants {#s2c}
------------

We recruited 660 members of the Research Now survey panel aged 18 years and older who reported having used ENDS at least once in their lifetime to complete the ENDS survey. Research Now is one of the major online survey panel companies with over 140 million finished surveys annually. Participants had to live in the USA and be able to complete an electronic survey in English. We specifically oversampled for older adults and minimum quotas to ensure near equal balance of gender.

Survey design {#s2d}
-------------

The survey was designed to include a best--worst scaling experiment related to ENDS use followed by a series of tobacco and ENDS-related questions. The survey included 19 best--worst scaling choice tasks, followed by questions on each participant's demographics, personality, current and past use of ENDS and tobacco products and prior attempts to quit tobacco use. Sawtooth Software was used to design the survey. Prior to the best--worst tasks, the survey provided an explanation for each of the attributes, as well as an example task involving car attribute preference followed by an example of a best--worst scaling task ([figure 1](#F1){ref-type="fig"}). The participants were told that some of the attributes were real but others were not and were asked, for the purposes of the study, to pretend they were all real and imagine each choice task as a new device. As opposed to other types of DCE methods where consumers choose between ENDS products, for each of the 19 choice tasks, participants selected one of five listed attribute levels that they felt most likely to encourage and least likely to encourage their use of a theoretical ENDS product. While other approaches such as a classical DCE would also yield importance scores, past studies demonstrated user fatigue and attribute dominance due to complex and overwhelming survey questions, whereas best--worst scaling, though not case 2, has been used in other areas of tobacco control.[@R20] Additionally, best--worst scaling case 2 methodology was preferred because it leads to scores on a common scale, permitting direct comparison between all attribute levels within the study, but not just direct comparisons among levels within the same attribute (as is the case for other DCE methods).[@R24] The 660 participants received 1 of 50 versions of the survey using a partial profile design. We sought efficiency by using a computer search algorithm to generate a design that showed each of a given attribute's levels an equal number of times (one-way level balance) and each pairing of a given attribute level with the levels of other attributes an equal number of times (two-way level balance that reduces correlations among the attributes). These two criteria will maximise both level balance and orthogonality, the two constituents of design efficiency for experimental design for a set of single profiles. Overall, each attribute level was seen about three times per participant (2.97), and each valid cross-attribute pair was seen not quite half the time by each participant (0.42 times). Reliable best--worst utilities can be obtained as long as each participant sees each level about three times.[@R26] The order of attributes varied across the survey blocks so that positional balance was maintained.

![Example of a best--worst scaling, case 2 task.](bmjopen-2018-027247f01){#F1}

Best--worst scaling attributes and levels {#s2e}
-----------------------------------------

The nine attributes were included with a definition in the survey. Their definitions can be found in online [appendix table 1](#SP1){ref-type="supplementary-material"}. For the rest of the paper, we will refer to these nine as *harms of use, general effects, cessation aid, purchase price, monthly cost, nicotine content, flavour availability, device design* and *modifiiability*.[@R16] We chose to divide cost into a separate purchase price and monthly cost attributes because of the variation that can be seen in each; the focus group members mentioned the two attributes separately as well. Rates of tobacco cessation for ENDS products were drawn from the evidence that ENDS are often used as a tobacco cessation aid regardless of actual effectiveness. It is worth noting that medications prescribed for assisting in tobacco cessation (eg, bupropion, varenicline, nicotine containing products) have 2 out of 10 success rate at best.[@R27] Nicotine content levels were drawn from the current spectrum of labelled nicotine concentrations.[@R28] In addition to the actual concentration, we included a label of 'none', 'low', etc., to denote where a particular concentration falls in the range of concentrations.
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Other measures {#s2f}
--------------

Participants responded to questions about sex, age, race and ethnicity, perceptions of general health,[@R29] education level and yearly household income. The survey then collected details about each participants' tobacco and ENDS use behaviours. Items included the heaviness of smoking index that asks participants 'At present, how long after waking do you wait before having your first cigarette (in mins)?' and 'How many cigarettes do you smoke per day at present?'[@R30] and other questions from the National Adult Tobacco Survey Questionnaire, 2012--2013, such as age of first cigarette, number of cigarettes smokes per day and smoking days per month.[@R31]

Analysis {#s2g}
--------

In DCEs, respondents are given tasks that combine possible varieties of product attributes and asked to make a choice, in our case, which attribute of the product was important to their use. With enough choice tasks, estimated importance scores can be generated, indicating which attribute most influenced their choices. The statistical model underlying best--worst scaling assumes that the relative choice probability of a given pair of best--worst choices is proportional to the distance between the two attribute levels on the latent utility scale. The pair of attribute levels chosen maximises the difference in the part-worth utilities for a given choice task. These distances between attribute levels are modelled as a difference model, with variations on best--worst scaling sometimes called 'maximum difference scaling'.[@R32] Using a multinomial regression model, these differences can provide the part-worth utilities relative to a single attribute level rather than relative to the sample mean.[@R24] Part-worth utilities are zero-centred numerical values that represent the relative desirability of the levels within each attribute. The higher the number, the more desirable the attribute's level is to participants. Importance scores were then calculated based on the difference between minimum and maximum part-worth utilities within an attribute.[@R25] The total importance of all attributes to a decision is 100%, with each attribute given a percentage of that total importance. Most important attribute was determined by comparing the importance scores for each individual, defining the attribute with the largest importance score as most important. In order to examine changes in attribute importance by age and gender, we performed a dependent *z*-test of proportions to compare the most important attribute with the next highest ranked attribute by age and gender.

Results {#s3}
=======

Of 900 individuals surveyed, 660 participants had used ENDS at least one time. Participants had a mean age of 42 years (SD ±19.4) with a range from 18 to 82 years and were evenly split women versus men (51% vs 49%) ([table 1](#T1){ref-type="table"}). Most participants were white (81%), making less than \$60 000 annually (60%) and self-reported very good or excellent health (60%). Sixty-four percent had used ENDS in the last 30 days. Almost all participants (92%) reported a history of traditional tobacco products and most (85%) had tried to quit tobacco in the past 12 months. Pearson's χ^2^ tests of the relation between age and tobacco use characteristics found statistically significant (p\<0.05) differences between subgroups of young (18--24 years), middle-aged (25--49 years) and older (50+ years) adults. For example, young adult participants were more likely to have used ENDS in the last 30 days (p=0.036) and to have used flavoured ENDS (p=0.012). Older adults were less likely to have used ENDS in the past 30 days (p\<0.001) and more likely to smoke one pack/day of traditional tobacco (p\<0.001) (see [table 2](#T2){ref-type="table"}).

###### 

Participants' characteristics, n (%)

  Characteristics                                                             Total, n=660   Age 18--24 years, n=169   Age 25--49 years, n=242   Age 50+ years, n=249
  --------------------------------------------------------------------------- -------------- ------------------------- ------------------------- ----------------------
  Age, mean (SD)                                                              42.0 (19.4)    22.2 (1.6)                32.1 (7.7)                65.0 (6.9)
  Female                                                                      *334 (51%)*    90 (53%)                  120 (49%)                 124 (50%)
  Race                                                                                                                                           
   White                                                                      *532 (81%)*    113 (67%)                 191 (79%)                 228 (92%)
   Black                                                                      *42 (6%)*      14 (8%)                   18 (7%)                   10 (4%)
   Asian-American                                                             *40 (6%)*      20 (12%)                  18 (7%)                   2 (1%)
   Other                                                                      *46 (7%)*      22 (13%)                  15 (6%)                   9 (4%)
  Hispanic or Latino/Latina                                                   *94 (14%)*     *42 (25%)*                45 (19%)                  7 (3%)
  College degree or higher                                                    *247 (37%)*    37 (22%)                  113 (47%)                 97 (38%)
  Overall health, very good or excellent                                      *396 (60%)*    110 (65%)                 160 (66%)                 126 (51%)
  Annual household income                                                                                                                        
   \$0 to \$29 999                                                            *149 (23%)*    52 (31%)                  51 (21%)                  46 (18%)
   \$30 000 to \$59 999                                                       *247 (37%)*    75 (44%)                  85 (35%)                  87 (35%)
   \$60 000 to \$89 999                                                       *156 (24%)*    25 (15%)                  73 (30%)                  58 (23%)
   \$90 000 or more                                                           *106 (16%)*    17 (10%)                  33 (14%)                  58 (23%)
  Knowledge that quitting smoking with help is more successful than without   *310 (47%)*    75 (44%)                  108 (45%)                 127 (51%)
   Used ENDS in last 30 days†                                                 *387 (64%)*    109 (71%)                 153 (69%)\*               125 (54%)\*
  Used flavoured ENDS in last 30 days, of current ENDS users‡                 *296 (70%)*    93 (79%)\*                134 (79%)\*               69 (52%)\*
   Anticipates ENDS use in next year                                          *478 (72%)*    121 (72%)                 193 (80%)\*               164 (66%)\*
   Ever used traditional tobacco products                                     *607 (92%)*    154 (91%)                 221 (91%)                 232 (93%)
   Age at first cigarette, mean (SD)†                                         *17 (6)*       16 (3)                    18 (5)                    18 (8)
   Smokes more than one pack/day§                                             *54 (12%)*     3 (3%)\*                  12 (8%)\*                 39 (23%)\*
  First smoke within 30 min of waking‡§                                       *256 (59%)*    48 (44%)\*                89 (59%)                  119 (70%)\*
  Tobacco quit attempt in past 12 months§                                     *369 (85%)*    87 (79%)\*                130 (85%)                 152 (89%)

\*P\<0.05; test versus total.

†n=607, 154, 221 and 232, respectively.

‡n=420, 117, 170 and 133, respectively.

§n=432, 110, 152 and 170, respectively.

ENDS, electronic nicotine delivery systems.

###### 

Final ENDS attributes, levels and mean utilities, n=660

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ENDS attributes                                                                  Levels of ENDS attributes                                                   Part-worth utilities,\
                                                                                                                                                               mean (95% CI)
  -------------------------------------------------------------------------------- --------------------------------------------------------------------------- ------------------------
  Harms of use                                                                     Less harmful on my body as compared with tobacco cigarettes                 88.96 (84.79 to 93.13)

  Unknown harm on my body as compared with tobacco cigarettes                      −19.24 (−21.32 to 17.17)                                                    

  Same amount of harm on my body as compared with tobacco cigarettes               −22.45 (−24.90 to 19.99)                                                    

  More harm on my body as compared with tobacco cigarettes                         −47.27 (−49.69 to 44.86)                                                    

  General effects of use                                                           Helps me breathe easier and my clothes do not smell like tobacco            58.37 (55.07 to 61.68)

  Helps me breathe easier but my clothes smell like tobacco                        −3.50 (−5.78 to 1.22)                                                       

  Does not help me breathe easier but my clothes do not smell like tobacco         −12.35 (−14.78 to 9.93)                                                     

  Does not help me breathe easier but still makes my clothes smell like tobacco    −42.52 (−45.15 to 39.89)                                                    

  Tobacco cessation                                                                7 of 10 people are able to quit tobacco cigarettes                          41.92 (39.36 to 44.47)

  5 of 10 people are able to quit tobacco cigarettes                               19.98 (18.20 to 21.76)                                                      

  2 of 10 people are able to quit tobacco cigarettes                               −12.79 (−14.84 to 10.73)                                                    

  People are not able to quit smoking tobacco cigarettes                           −49.11 (−52.46 to 45.75)                                                    

  Purchase price of product                                                        \$5 one-time purchase                                                       52.41 (49.12 to 55.70)

  \$55 one-time purchase                                                           12.40 (11.02 to 13.77)                                                      

  \$115 one-time purchase                                                          −26.04 (−27.92 to 24.17)                                                    

  \$175 one-time purchase                                                          −38.76 (−40.95 to 36.57)                                                    

  Monthly cost of use                                                              \$5 per month to use                                                        47.50 (44.72 to 50.29)

  \$25 per month to use                                                            16.68 (15.00 to 18.37)                                                      

  \$65 per month to use                                                            −22.16 (−23.91 to 20.42)                                                    

  \$100 per month to use                                                           −42.03 (−44.37 to 39.68)                                                    

  Nicotine content\*                                                               None (0 mg/mL)                                                              10.89 (6.83 to 14.96)

  Low (6 mg/mL)                                                                    18.29 (16.16 to 20.41)                                                      

  Medium (12 mg/mL)                                                                2.11 (−0.01 to 4.23)                                                        

  High (24 mg/mL)                                                                  −31.30 (−35.12 to 27.47)                                                    

  Flavour availability                                                             Available in fruit, candy, coffee, wine and other flavours                  15.88 (13.32 to 18.44)

  Available in tobacco and menthol flavours                                        13.50 (11.94 to 15.05)                                                      

  Available without any flavours                                                   −29.38 (-32.27 to 26.48)                                                    

  Device design                                                                    Very similar in size, weight, appearance, and feel to a tobacco cigarette   12.85 (11.16 to 14.54)

  Somewhat similar in size, weight, appearance, and feel to a tobacco cigarette    14.47 (12.87 to 16.07)                                                      

  Not similar at all in size, weight, appearance and feel to a tobacco cigarette   −27.32 (-29.98 to 24.66)                                                    

  Modifiability                                                                    Various parts can be modified                                               12.46 (10.68 to 14.23)

  It cannot be modified                                                            −12.46 (-14.23 to 10.68)                                                    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Nicotine levels corresponded to what the current literature designated as low, medium and high levels of nicotine.

ENDS, electronic nicotine delivery systems.

Importance of ENDS attributes overall and by subgroup {#s3a}
-----------------------------------------------------

The overall importance scores for the nine attributes are found in [figure 2](#F2){ref-type="fig"}. The attributes had the following importance distribution: *harms of use* 17.6%; *general effects* 14.1%; *cessation aid* 12.6%; *purchase price* 12.1%; *monthly cost* 12.0%; *nicotine content* 11.4%; *flavour availability* 8.4%; *device design* 7.2% and *modifiability* 4.6%. Independent t-tests of the importance scores by gender found that when compared with men, women participants were more likely to give importance to *harms of uses* (∆+9.7%; p\<0.001) and *general effects* (∆+8.1%; p=0.002) and less likely to give importance to *purchase price* (∆−8.3%; p=0.011) and *monthly cost* (∆−6.8%; p=0.008).

![Importance of ENDS characteristics, n=660. ENDS, electronic nicotine delivery systems.](bmjopen-2018-027247f02){#F2}

Numerous statistically significant differences were found by age subgroups. Younger adults compared with middle-aged and older adults together were more likely to give importance to *modifiability* (∆+22%; p=0.004) and less likely to give importance to *purchase price* (∆−11%; p=0.006). Middle-aged adults compared with young and older adults together were more likely to give importance to *modifiability* (∆+24%; p=0.001) and less likely to give importance to *harms of use* (∆−5%; p=0.027). Older adults compared with middle-aged and young adults together were more likely to give importance to *purchase price* (∆+11%; p=0.004) and less likely to give importance to *modifiability* (∆−34%; p\<0.001).

Part-worth utilities of ENDS attribute levels {#s3b}
---------------------------------------------

The part-worth utility scores for the levels of the nine attributes are shown in [table 2](#T2){ref-type="table"}. *Harms of use* had the level with the highest part-worth utility of 88.96 (90% CI: 84.79, 93.13), followed by *general effects* with a level at 58.37 (90% CI: 55.07, 61.68) and *purchase price* at 52.41 (90% CI: 49.12, 55.70). *Cessation aid* had the level with the lowest part-worth utility of −49.11 (90% CI: −52.46,--45.75), followed by *harms of use* at −47.27 (90% CI: −49.69,--44.86).

Most important ENDS attribute overall and by subgroup {#s3c}
-----------------------------------------------------

After examining the importance scores for each individual, *harms of uses* was the most important attribute for 49% of participants ([table 3](#T3){ref-type="table"}). *Nicotine content* was next most frequent (13%) and *purchase price* was third (12%). A goodness-of-fit χ^2^ test determined that the nine attributes differed from expected and thus were not equally distributed among participants (p\<0.001). Also, dependent *z*-tests of the proportions of the second through ninth ranked attributes against *harms of use* found that all were significantly lower ranked and were less likely to be chosen as most important (range: ∆−83%--99%; p\<0.001). Aside from *nicotine content* compared with *harms of use*, stepped tests of each attribute against its nearest found that only *device design* (p=0.005) and *modifiability* (p=0.020) were statistically significantly less important.

###### 

Most important attribute, n (%)

  -----------------------------------------------------------------------------------------------------------------------------------
  ENDS characteristics        Total\       Age 18--24 years n=169   Age 25--49 years n=242   Age 50+ years\   Male\       Female\
                              n=660                                                          n=249            n=326       n=334
  --------------------------- ------------ ------------------------ ------------------------ ---------------- ----------- -----------
  Harms of use                326 (49%)    74 (44%)                 114 (47%)                138 (55%)†       149 (46%)   177 (53%)

  Nicotine content            85 (13%)\*   26 (15%)                 32 (13%)                 27 (11%)         42 (13%)    43 (13%)

  Purchase price of product   77 (12%)     14 (8%)                  30 (12%)                 33 (13%)         42 (13%)    35 (10%)

  General effects of use      56 (9%)      26 (15%)†                13 (5%)†                 17 (7%)          24 (7%)     32 (10%)

  Tobacco cessation aid       45 (7%)      11 (6%)                  16 (7%)                  18 (7%)          28 (9%)     17 (5%)

  Flavour availability        32 (5%)      10 (6%)                  18 (7%)†                 4 (2%)†          18 (5%)     14 (4%)

  Monthly cost of use         27 (4%)      7 (4%)                   11 (5%)                  9 (4%)           17 (5%)     10 (3%)

  Device design               10 (2%)\*    1 (1%)                   6 (2%)                   3 (1%)           6 (2%)      4 (1%)

  Modifiability               2 (0%)\*     0 (0%)                   2 (1%)                   0 (0%)           0 (0%)      2 (1%)
  -----------------------------------------------------------------------------------------------------------------------------------

\* P\<0.05 versus next higher ranked attribute for total sample.

†P\<0.05 versus total sample for age groups.

The nine attributes also statistically significantly differed from the expected distribution by the subgroups for age and gender (p\<0.001). Pearson's Χ^2^ tests of the relation between the age subgroups and most important attribute found that *general effects* was the most important attribute for younger adults as compared with other ages (p\<0.001). Compared with younger and older adults, *general effects* was less likely to be the most important attribute for middle-aged adults (p=0.029) and *flavour availability* was more likely to be most important (p=0.018). Compared with both younger and middle-aged adults, *harms of use* was more likely to be important (p=0.016) and *flavour availability* was less likely to be important (p=0.003). There were no statistically significant differences in the distribution of most important attributes by gender although *harms of use* (p=0.061) and *cessation aid* (p=0.075) approached significance.

Discussion {#s4}
==========

In our study of US adult ENDS consumers, we found that *harms of use* had the highest importance to consumers' choice of an ENDS product. Other than cost (ie, *purchase price* and *monthly cost*), the attributes with the highest importance scores hinged on consumers' perceptions of efficacy as a harm reduction strategy (*harms of use)*, health benefit (*general effects*) and tobacco cessation (*cessation aid*), respectively. Consumers of different ages varied in importance they placed on different ENDS product characteristics. As more evidence about these products' ability to benefit or harm consumers is more fully understood, public health initiatives could target these perceptions. Variation by consumer group existed, which may allow for targeted interventions to reduce or enhance ENDS use in any given consumer group.

ENDS products are marketed as healthier than combustible tobacco products,[@R34] but the evidence regarding the impact of ENDS products on human health is slowly emerging. National Academies of Science, Engineering, and Medicine recently released a report on the public health consequences of ENDS products.[@R35] While there is substantial evidence that, except for nicotine, exposure to potentially toxic substances from ENDS is significantly lower compared with combustible tobacco products, there is also substantial evidence that exposure to ENDS aerosols can induce lung dysfunction and oxidative stress in human tissue.[@R36] The long-term effects on cardiovascular outcomes, cancer or other health conditions are unclear. Our work should add a sense of urgency to the push for ongoing research into the evidence for and against ENDS products as a harm reduction strategy. The idea that an ENDS product was less harmful than tobacco cigarettes was extremely important to participants' choice. The level that the product was 'less harmful on my body as compared with tobacco cigarettes' had the highest part-worth utility of any attribute (88.96). Moreover, the level that the product 'had the same amount of harm on my body as compared with tobacco cigarettes' caused people to avoid choosing that product and had a negative utility (−22.45). Both the *health effects* and the use as a *cessation aid* had levels that are likely healthier and of more help in cessation than the evidence suggests. Yet in general, perceptions, including misperceptions, affect smokers' behaviour.[@R37] The look and feel of cigarette packaging appears to influence consumers' use and may affect their perceptions' of the healthiness and harm of the cigarettes within.[@R38] A study of combustible tobacco labelling revealed that 'additive-free' or 'natural' labels on current cigarette brands were misperceived to be possibly less harmful than other brands of cigarettes and may reduce the efficacy of public health initiatives.[@R39] Even efforts by the Federal Trade Commission to prohibit language that might create misperceptions of reduced harm in tobacco cigarettes has been unsuccessful.[@R37] This (mis)perception of harm and health appears to strongly influence the choice of ENDS products. Further efforts, including those studying clear labelling and health warnings, are needed to explore how to align ENDS users' perceptions of ENDS products with the evidence.

While *harms of use* had the highest importance score, the combined importance of *purchase price* and *monthly cost* was greater than *harms of use*, so the importance of financial burden on ENDS use should not be underestimated. If we combine the two cost-related attributes, *purchase price* and *monthly cost*, overall cost's importance score would be 24.1% as compared with 17.6% for *health effects*. A recent study of the cross-price elasticity of ENDS and tobacco cigarettes found that ENDS are partially substitutable for cigarettes.[@R40] However, the availability of ENDS also reduced the number of individuals who reported they would quit smoking if cigarette costs increased by 20% (50.2% to 30.0%), revealing that ENDS may discourage smokers from quitting completely.[@R41] Additionally, increase in the cost of ENDS products may shift consumers back towards combustible tobacco, though recent simulations found no relationship between cigarette prices and ENDS use.[@R42] Taxation may reduce ENDS use but further work is needed to model the consequences of cost increase on ENDS use.

Potentially meaningful differences were found in the importance of ENDS product attributes and the most important attribute by different age groups. Younger and middle-aged adults found *modifiability* to be more important than older adults. While we did not see gender differences for attribute preferences, a Canadian DCE study of young women found that pack structure was the most important attribute driving ENDS use.[@R14] The shape and structure of the device and packaging may be more important to a younger population. Younger adults were more likely to have *general effects* as their most important attribute while *flavour availability* was more likely to be most important to middle-aged adults and significantly less likely to be most important to older adults. A systematic review of studies of consumers' preference for flavour found it to be likely important to young people.[@R7] However, as with our own qualitative study, which was included in the review, many of the included studies did not have experimental designs.[@R16] Interestingly, another Canadian DCE study of ENDS use found that younger smokers perceived cherry flavour as less harmful while older adults found tobacco flavour less harmful.[@R15] While we found *flavour availability* was more important to middle-aged adults, we did not find older adults favoured tobacco flavour. However, both of these studies found that attributes related to the users' health (*harms of use* in our case and health warnings in the Canadian study) were more important than flavour, and thus efforts to regulate flavours may not reduce ENDS use as much as other regulations on other attributes, such as *harms of use*.

Our study has several important limitations. First, our study examines choice behaviour and not actual purchase behaviour. While we drew from a national online survey panel, our respondent population is limited to a convenience sample. Additionally, best--worst scaling can be subject to attribute non-attendance where participants either fail to pay attention to an attribute or attributes, or attribute dominance where participants only pay attention to a single attribute. We found that only about 2% of participants did not attend to the majority of attributes, though about 16% failed to attend to at least one attribute. No participant showed dominance behaviour. While there was some attribute non-attendance, best--worst scaling inclines participants to make judgements about more attributes and does not invite as much attribute non-attendance or dominance as can be seen in other standard DCEs. However, it seems more likely that socially desirable responses could bias respondents' choices within best--worst scaling than other DCEs.[@R24] Lastly, while we did extensive pretesting, it is possible that different participants interpreted different attributes and levels differently. For example, it is possible that participants viewed the monthly cost of use in relation to their own use and thus the responses to monthly cost may need to be viewed with caution.

Conclusion {#s5}
==========

A variety of ENDS product attributes are important to consumers. *Harms of use* had the highest importance to consumers' choice of an ENDS product. Other than cost, the attributes with the highest importance scores hinged on consumers' perceptions of efficacy as a harm reduction strategy (*harms of use)*, general benefit (*general effects*) and tobacco cessation (*cessation aid*), respectively. Consumers differed by age group in some of the more important attributes. Though the overall importance of ENDS product attributes was similar, efforts to increase or decrease ENDS use could be tailored to these group differences.

Supplementary Material
======================

###### Reviewer comments

###### Author\'s manuscript

We would also like to thank CHAI Core's Maihan Vu (MV) and Randall Teal (RT) for qualitative coding expertise. We would like to thank Trisha Crutchfield for her project management.

The work reported in this paper was conducted by CHAI Core (Communication for Health Applications and Interventions), who is supported in part by a grant from NIH (DK056350) to the University of North Carolina Nutrition Obesity Research Center and from NCI (P30-CA16086) to the UNC Lineberger Comprehensive Cancer Center.

**Contributors:** CEK, LMR, ELS, KC, MB, GAZ and AOG all contributed to the conceptualisation and design of the survey. CK and KC assisted with data collection. CK, LMR, ELS, KC, CJW, CE, CM, MB, GAZ and AOG participated in the analysis of the data. All authors contributed to the content and reviewed the manuscript prior to submission.

**Funding:** The University of North Carolina at Chapel Hill University Cancer Research Fund at the Lineberger Comprehensive Cancer Center supported this work. The attributes and factors in the experiment were developed with the assistance of the CHAI Core (Communication for Health Applications and Interventions), who is supported by the National Institutes of Health (DK056350) and the National Institutes for Health at the National Cancer Institute (P30 CA16086).

**Competing interests:** None declared.

**Ethics approval:** The institutional review board at the University of North Carolina at Chapel Hill approved this study.

**Provenance and peer review:** Not commissioned; externally peer reviewed.

**Data sharing statement:** Data can be requested from Christine_Kistler\@med.unc.edu.

**Patient consent for publication:** Not required.
